Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Prior to mixing, allow the vial to reach ambient room temperature to prevent condensation
Mouse monoclonal anti-GAPDH antibody (1:1000
The New York State Athletic Commission reported a failed drug test in the lead-up to Garcias fight with Devin Haney
2079-A NASH CIRRHOSIS: DISTINCT PHENOTYPICAL DIFFERENCES, MORE SYSTEMIC INFLAMMATION, AND MORE FRAIL THAN VIRAL-RELATED CIRRHOSIS Yu JUN Wong 1,2 , Heng Yi Tan 3 , Siew Yoon Yap 4 , Geraldine Lim 4 , Seok Hwee Khoo 4 , Jessica Tan 1 , Rahul Kumar 1,2 , Joan Khoo 5 , Rosario Helen Barbara 6 and Paul Edward Hutchinson 3 , (1)Department of Gastroenterology & Hepatology, Changi General Hospital, (2)Duke-Nus Medical School, Singhealth, (3)Flow Cytometry Laboratory, Life Sciences Institute, National University of Singapore, (4)Clinical Trial Research Unit, Changi General Hospital, (5)Department of Endocrinology, Changi General Hospital, (6)Department of Geriatric Medicine, Changi General Hospital Background: NASH is replacing viral hepatitis as the fastest-growing etiology of liver cirrhosis globally with limited therapeutic options
US$ 26.10
US$ 28.23
US$ 24.49
US$ 23.66
US$ 23.09
US$ 25.07
US$ 24.96
US$ 24.48
